Search filters

List of works by David L Veenstra

A Bayesian approach to aid in formulary decision making: incorporating institution-specific cost-effectiveness data with clinical trial results

scientific article

A Framework for Prioritizing Research Investments in Precision Medicine

scientific article

A Model of Cost-effectiveness of Tissue Plasminogen Activator in Patient Subgroups 3 to 4.5 Hours After Onset of Acute Ischemic Stroke ⬇️

scientific article published on May 24, 2012

A formal risk-benefit framework for genomic tests: Facilitating the appropriate translation of genomics into clinical practice ⬇️

scientific article published on November 1, 2010

A guideline for the use of pharmacoeconomic models of diabetes treatment in the US managed-care environment

scientific article

A review of public policy issues in promoting the development and commercialization of pharmacogenomic applications: challenges and implications

article

A review of selected patient-generated outcome measures and their application in clinical trials

scientific article published on September 2003

Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States

scientific article published on 01 November 2019

An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis

scientific article published on 23 April 2009

An introduction to cost-effectiveness and cost–benefit analysis of pharmacogenomics ⬇️

scientific article published on May 1, 2003

Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy

scientific article published on 01 August 2019

Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research ⬇️

scientific article published on July 1, 2012

Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group

scientific article published on 7 September 2012

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine

scientific article

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine

article

Clinical exome sequencing vs. usual care for hereditary colorectal cancer diagnosis: A pilot comparative effectiveness study

scientific article published on 07 August 2019

Clinical verification of genetic results returned to research participants: findings from a Colon Cancer Family Registry

scientific article published on 23 August 2017

Comparative clinical and economic outcomes of treatments for refractory non-small cell lung cancer (NSCLC).

scientific article

Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes

journal article published in 2014

Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia

scientific article published on 01 August 2019

Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

scientific article published on 01 May 2019

Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B.

scientific article published in January 2007

Cost of chronic hepatitis B infection in the United States

scientific article published in November 2004

Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia

scientific article published on 01 December 2018

Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome

scientific article published on 26 July 2020

Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer.

scientific article

Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States

scientific article published on 01 October 2020

Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan

scientific article published in September 2007

Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom

scientific article published on 01 August 2007

Cost-effectiveness of population genomic screening

scientific article published on 01 December 2019

Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke: current evidence

scientific article published on 04 September 2014

Cytochrome p450 enzyme polymorphism frequency in indigenous and native american populations: a systematic review

scientific article published on 26 March 2008

Demand for Precision Medicine: A Discrete-Choice Experiment and External Validation Study

scientific article published on 01 January 2020

Design, implementation, and first-year outcomes of a value-based drug formulary

scientific article published on April 2015

Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group

scientific article

Do cancer treatments have option value? Real-world evidence from metastatic melanoma

scientific article published on 01 July 2019

Economic analyses of human genetics services: a systematic review

scientific article

Epidermal growth factor receptor genomic variation in NSCLC patients receiving tyrosine kinase inhibitor therapy: a systematic review and meta-analysis

scientific article published on 09 May 2009

Facilitating comparative effectiveness research in cancer genomics: evaluating stakeholder perceptions of the engagement process ⬇️

scientific article published on July 1, 2012

Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support

scientific article

Gene expression profiling and breast cancer care: what are the potential benefits and policy implications?

scientific article published in July 2005

Genetic Variant Reinterpretation: Economic and Population Health Management Challenges

scientific article published on 09 September 2020

Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs

scientific article published in July 2004

Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research ⬇️

scientific article published on October 4, 2012

HBeAg-negative chronic hepatitis B: cost-effectiveness of peginterferon alfa-2a compared to lamivudine in Taiwan

scientific article

Harmonizing Outcomes for Genomic Medicine: Comparison of eMERGE Outcomes to ClinGen Outcome/Intervention Pairs

article

Health Years in Total: A New Health Objective Function for Cost-Effectiveness Analysis

scientific article published on 24 December 2019

Health state preference assessment in diabetic peripheral neuropathy

scientific article published on 01 January 2002

Health-care referrals from direct-to-consumer genetic testing ⬇️

scientific article published on October 28, 2010

How Comparative Effectiveness Research Can Help Advance ‘Personalized Medicine’ In Cancer Treatment ⬇️

scientific article published on December 1, 2011

How Does Option Value Affect the Potential Cost-Effectiveness of a Treatment? The Case of Ipilimumab for Metastatic Melanoma

scientific article published on 17 May 2019

How can clinical researchers quantify the value of their proposed comparative research?

scientific article published on 08 December 2018

Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting.

scientific article published on September 2016

Improving the Efficiency and Quality of the Value Assessment Process for Companion Diagnostic Tests: The Companion test Assessment Tool (CAT)

scientific article (publication date: August 2015)

Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update

scientific article published on 06 September 2012

Integrating comparative effectiveness design elements and endpoints into a phase III, randomized clinical trial (SWOG S1007) evaluating oncotypeDX-guided management for women with breast cancer involving lymph nodes ⬇️

scientific article published on September 18, 2012

Next Generation Sequencing in the Clinic: a Patterns of Care Study in a Retrospective Cohort of Subjects Referred to a Genetic Medicine Clinic for Suspected Lynch Syndrome.

scientific article published on 5 December 2015

Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis

scientific article published on 4 May 2015

Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making

scientific article published on 01 January 2021

Participant Attitudes Toward an Intensive Trial of Multiple Biopsies, Multidimensional Molecular Analysis, and Reporting of Results in Metastatic Triple-Negative Breast Cancer

scientific article published on 16 August 2017

Patient preferences for massively parallel sequencing genetic testing of colorectal cancer risk: a discrete choice experiment

Payer Preferences and Willingness to Pay for Genomic Precision Medicine: A Discrete Choice Experiment

scientific article published on 01 April 2020

Paying for personalized care: Cancer biomarkers and comparative effectiveness ⬇️

scientific article published on March 6, 2012

Pharmacoeconomic evaluations in the treatment of non-small cell lung cancer

scientific article published on January 2008

Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin

scientific article published on February 2008

Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes

scientific article published on October 2007

Potential Cost-Effectiveness of Universal Access to Modern Contraceptives in Uganda ⬇️

scientific article published on February 17, 2012

Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials

scientific article published on 29 December 2015

Provider preferences for resolving uncertainty and avoiding harms in precision medicine: a discrete choice experiment

scientific article published on 17 August 2020

Psychological outcomes related to exome and genome sequencing result disclosure: a meta-analysis of seven Clinical Sequencing Exploratory Research (CSER) Consortium studies

scientific article published on 13 June 2019

Relationship between genetic knowledge and familial communication of CRC risk and intent to communicate CRCP genetic information: insights from FamilyTalk eMERGE III

scientific article published on 24 June 2020

Research Directions in Genetic Predispositions to Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis.

scientific article published on 6 November 2017

Response to Phillips et al.

scientific article published in April 2015

Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT).

scientific article

Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study

article

Social and behavioral research in genomic sequencing: approaches from the Clinical Sequencing Exploratory Research Consortium Outcomes and Measures Working Group

scientific article

Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment

scientific article

Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement ⬇️

scientific article published on March 1, 2012

Stakeholder perspectives on a risk-benefit framework for genetic testing

scientific article published on 20 April 2010

Stakeholder perspectives on decision-analytic modeling frameworks to assess genetic services policy ⬇️

scientific article published on July 26, 2012

Targeted erlotinib for first-line treatment of advanced non-small cell lung cancer: a budget impact analysis

scientific article published on 12 May 2014

The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations

scientific article published on 01 September 2018

The Cost-Effectiveness of Primary Stroke Centers for Acute Stroke Care ⬇️

scientific article published on April 25, 2012

The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation

scientific article published on 01 September 2018

The budget impact and cost-effectiveness of defibrotide for treatment of veno-occlusive disease with multi-organ dysfunction in patients post-hematopoietic stem cell transplant

scientific article published on 23 December 2016

The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma

scientific article published in November 2005

The cost-effectiveness of returning incidental findings from next-generation genomic sequencing

scientific article published on 13 November 2014

The economic value of innovative treatments over the product life cycle: the case of targeted trastuzumab therapy for breast cancer

scientific article

The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer

scientific article published on 18 July 2008

The use of real-world evidence in ICER's scoping process and clinical evidence assessments

scientific article published on 01 December 2020

Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests

scientific article

Tumor marker usage and medical care costs among older early-stage breast cancer survivors

scientific article

Use of real-world evidence in economic assessments of pharmaceuticals in the United States

scientific article published on 01 January 2021

Value-of-Information Analysis within a Stakeholder-Driven Research Prioritization Process in a US Setting: An Application in Cancer Genomics ⬇️

scientific article published on May 1, 2013

Paulina is supported by:

About Paulina

Help